Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Detection of Numerical Abnormalities of Chromosome 9 and p16/CDKN2A Gene Alterations in Ovarian Cancer with Fish Analysis

CHRISTOS ARAVIDIS, ANNA D. PANANI, ZOI KOSMAIDOU, NIKOLAOS THOMAKOS, ALEXANDROS RODOLAKIS and ARISTEIDIS ANTSAKLIS
Anticancer Research December 2012, 32 (12) 5309-5313;
CHRISTOS ARAVIDIS
1Critical Care Department, Cytogenetics Unit, Evangelismos Hospital, Medical School of Athens University, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: christos.aravidis{at}yahoo.gr
ANNA D. PANANI
1Critical Care Department, Cytogenetics Unit, Evangelismos Hospital, Medical School of Athens University, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZOI KOSMAIDOU
2Department of Genetics, Alexandra Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NIKOLAOS THOMAKOS
3Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School of Athens University, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALEXANDROS RODOLAKIS
3Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School of Athens University, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARISTEIDIS ANTSAKLIS
3Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School of Athens University, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 32 no. 12 5309-5313
PMID 
23225431

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 26, 2012
  • Revision received October 26, 2012
  • Accepted October 29, 2012
  • Published online December 6, 2012.

Copyright & Usage 
Copyright© 2012 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. CHRISTOS ARAVIDIS1⇓,
  2. ANNA D. PANANI1,
  3. ZOI KOSMAIDOU2,
  4. NIKOLAOS THOMAKOS3,
  5. ALEXANDROS RODOLAKIS3 and
  6. ARISTEIDIS ANTSAKLIS3
  1. 1Critical Care Department, Cytogenetics Unit, Evangelismos Hospital, Medical School of Athens University, Athens, Greece
  2. 2Department of Genetics, Alexandra Hospital, Athens, Greece
  3. 3Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School of Athens University, Greece
  1. Correspondence to: Dr. Christos Aravidis, Department of Cancer Genetics, Centrum for Molecular Medicine, Karolinska University Hospital, L8:02 Stockholm171 76, Sweden. Tel: +46 739572851, e-mail: christos.aravidis{at}yahoo.gr
View Full Text

Statistics from Altmetric.com

Cited By...

  • 15 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 32, Issue 12
December 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Detection of Numerical Abnormalities of Chromosome 9 and p16/CDKN2A Gene Alterations in Ovarian Cancer with Fish Analysis
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Detection of Numerical Abnormalities of Chromosome 9 and p16/CDKN2A Gene Alterations in Ovarian Cancer with Fish Analysis
CHRISTOS ARAVIDIS, ANNA D. PANANI, ZOI KOSMAIDOU, NIKOLAOS THOMAKOS, ALEXANDROS RODOLAKIS, ARISTEIDIS ANTSAKLIS
Anticancer Research Dec 2012, 32 (12) 5309-5313;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Detection of Numerical Abnormalities of Chromosome 9 and p16/CDKN2A Gene Alterations in Ovarian Cancer with Fish Analysis
CHRISTOS ARAVIDIS, ANNA D. PANANI, ZOI KOSMAIDOU, NIKOLAOS THOMAKOS, ALEXANDROS RODOLAKIS, ARISTEIDIS ANTSAKLIS
Anticancer Research Dec 2012, 32 (12) 5309-5313;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and Cervical Cancer Cells
  • Transcriptional Regulation of the p16 Tumor Suppressor Gene
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies

Keywords

  • Ovarian cancer
  • genetic changes
  • chromosome 9 numerical abnormalities
  • p16CDKN2A gene deletion
  • FISH technique
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire